Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Cáncer de la Tiroides / Recursos de NCI
|
NCI CANCERLIT® Search: Thyroid Cancer - October 2001
Multicentre study of thyroid nodules in patients with Graves' disease. Multicentre study of thyroid nodules in patients with Graves' disease (Br J Surg 2000; 87: 1111-13). An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 ... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - September 2001
Table of ContentsAnalysis of the results of phase III controlled clinical trials with recombinant human thyrotropin: developing a clinical guide.Role of ultrasonography in the diagnosis and management of thyroid cancer.Management of thyroid... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - April 2002
Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - August 2002
Cancer after nuclear fallout: lessons from the Chernobyl accident. Interlaboratory comparison of thyroglobulin measurements for patients with recurrent or metastatic differentiated thyroid cancer. Final report of Hanford Thyroid Disease Study... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - February 2002
[Management of the neck for patients with thyroid papillary carcinoma] [Childhood thyroid carcinoma: an analysis of 14 cases] Preoperative evaluation of patients with parathyroid adenoma: role of high-resolution ultrasonography. Medullary... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - January 2002
Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? Usefulness of the diagnostic total body scan in differentiated thyroid cancer. Relationship between expression of the sodium/iodide... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - July 2002
Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment. Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment (EJSO 2001; 27:157-161). Reduced HBME-1 immunoreactivity of papillary... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - June 2002
Role of color flow Doppler sonography in pre-operative diagnostics of the thyroid pathology. Thyroid carcinoma at King Edward VIII Hospital, Durban, South Africa. Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - March 2002
Surgical treatment strategy for thyroid gland carcinoma nodal metastases. Parathyroid carcinoma. Fine needle aspiration cytology of thyroid nodules: how accurate is it and what are the causes of discrepant cases? Secondary thyroid... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - May 2002
Intraoperative management of the thyroid gland in laryngeal cancer surgery. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain Metastatic... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - October 2002
Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET. Preoperative localization of parathyroid adenomas: the protagonist's view. Preoperative localization of parathyroid adenomas: the antagonist's view. Preoperative... |
|
|
NCI CANCERLIT® Search: Thyroid Cancer - September 2002
Differentiated thyroid cancer in children and adolescents. The finding of a somaticdeletion in RET exon 15 clarified the sporadic nature of amedullary thyroid carcinoma suspected to be familial. Ultrasonography: is it useful in the diagnosis... |
|
|
NCI/PDQ® Health professionals: Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)
TABLE OF CONTENTS IntroductionMultiple Endocrine Neoplasia Type 1Clinical DescriptionParathyroid Tumors and PHPTPNETsPituitary TumorsOther MEN1-Associated TumorsMaking the Diagnosis of MEN1Molecular Genetics of MEN1Genetic Testing and Differential... |
|
|
NCI/PDQ® Health professionals: Parathyroid Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Parathyroid Cancer Cellular Classification of Parathyroid CancerStage Information for Parathyroid CancerTreatment Option OverviewLocalized Parathyroid CancerCurrent Clinical TrialsMetastatic Parathyroid... |
|
|
NCI/PDQ® Health professionals: Thyroid Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Thyroid CancerIncidence and MortalityRisk FactorsPrognostic FactorsRelated SummariesCellular Classification of Thyroid CancerStage Information for Thyroid CancerDefinitions of TNMPapillary and Follicular... |
|
|
NCI/PDQ® Patients: Parathyroid Cancer
TABLE OF CONTENTS DescriptionWhat is parathyroid cancer?Stage ExplanationStages of parathyroid cancerLocalizedMetastaticRecurrentTreatment Option OverviewHow parathyroid cancer is treatedTreatment by stageLocalized Parathyroid CancerMetastatic... |
|
|
NCI/PDQ® Patients: Thyroid Cancer Treatment (PDQ®)
TABLE OF CONTENTS DescriptionWhat is thyroid cancer?Stage ExplanationStages of thyroid cancerPapillary and follicular thyroid cancerMedullary thyroid cancerAnaplastic thyroid cancerRecurrent thyroid cancerTreatment Option OverviewHow thyroid cancer... |
Ms. Wagner discusses diet during cancer treatment and balancing nutritional needs and side effects. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

